Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2025-12-24 @ 6:47 PM
NCT ID:
NCT02930057
Eligibility Criteria:
Inclusion Criteria:
* men and women
* age ≥18 years old,
* pain intensity≥4 out of 10 on the numerical rating scale (NRS),
* chronic lumbosacral radicular pain lasting ≥12 weeks,
* dominant leg pain with less intense back pain,
* the previous failure of conservative management such as physiotherapy, exercise therapy, or analgesic medications.
* segmental pain of a radicular nature originating from the lumbar segments and with a shooting or lancinating quality corresponding to a dermatome suggestive of the involved nerve root.
* availability of computed tomography/magnetic resonance imaging findings of pathology concordant with the side and level of their clinical features.
Exclusion Criteria:
* patient refusal to participate in the study,
* age \<18 years,
* pregnant or nursing
* pain \<4-points on NRS,
* acute pain of onset lasting\<12 weeks,
* progressive motor weakness in the affected leg,
* allergies to local anesthetics, contrast dyes or steroids
* significant anatomic deformity (either congenital or acquired) making it difficult to access the foramen as evidenced by computed tomography/magnetic resonance imaging
* presence of cancer accounting for back pain
* patients with platelet dysfunction, bleeding disorder or continuing anticoagulant treatment
* steroid injection within the previous 12 weeks,
* systemic infection,
* injection site infection,
* unstable medical or psychiatric condition
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02930057
Study Brief:
Protocol Section:
NCT02930057